Recently, the Mazda brand announced the sales report for January and March, a total of 36,000 units, this number may seem a little too low on some other hot brands, that is, the sales of some hot models for one or two months, but Mazda is niche after all, and the market has not been very good this year. In addition, sales in March were announced at 8,608 units, which is actually not a very good number.
Specifically, the top three sales in January-March 2022 are Onksela, CX-5 and CX-30, and since Changan Mazda and FAW Mazda have merged, this ranking is the best selling three cars in the Mazda brand.
First of all, look at the Onksela, this car is positioned as a compact sedan, which is the sales pillar of the Mazda brand, with a total of 21,347 units sold from January to March this year, which is a good result. Compact cars themselves are the hot selling category in the mainland, and The Axelas like it with its sporty and unique appearance.
In second place is the CX-5, which sold 5837 units in January-March this year, which can be seen to be quite different from the sales volume of Axela. On the one hand, the CX-5 is positioned as a compact SUV, but the price is starting from 175,800 yuan, and the 2.5L engine model is sold from 205,800 yuan, even if there is a certain discount at present, it is not as affordable as the price of other cars of the same level. On the other hand, because of the powertrain of the CX-5, the 2.0L engine has a maximum horsepower of 155 Ps and a maximum torque of 200 N·m, which is still a bit difficult to drag the body of about 1.5 tons.
The third place is CX-30, the price is close to the people, the lowest 129,900 yuan to sell, but the configuration is a little bit not very good to see, low with three versions of the radar are not given, but gave 7 air bags, the operation is a bit confused.
GO Chejun comments: On the whole, Mazda's sales in March are not good, but in this context, it is not particularly bad, and it is expected that April will be affected by the national form, and it may fall.